Whither the impending european regulation of presumed endocrine disruptors?

Affiliations

• ¹ Institute of Public Health, University of Aarhus, Aarhus, Denmark. Electronic address: [email protected].
• ² Queen Mary, London, UK. Electronic address: [email protected].
• ³ Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA. Electronic address: [email protected].
• ⁴ Department of Toxicology and Applied Hygiene, University of Bordeaux, Bordeaux, France. Electronic address: [email protected].
• ⁵ UNESP Medical School, Botucatu 18600 SP, Brazil. Electronic address: [email protected].
• ⁶ University of Wuerzburg, Wuerzburg, Germany. Electronic address: [email protected].
• ⁷ Human and Environmental Toxicology, University of Konstanz, Konstanz, Germany. Electronic address: [email protected].
• ⁸ Section of Toxicology and Risk Assessment, Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy. Electronic address: [email protected].
• ⁹ Michigan State University, East Lansing, MI, USA. Electronic address: [email protected].
• ¹⁰ Regulatory Toxicology and Pharmacology, Bethesda, MD, USA. Electronic address: [email protected].
• ¹¹ Toxicology, Technical University of Munich, Munich, Germany. Electronic address: [email protected].
• ¹² Department of Environmental Health, Indiana University, Bloomington, IN 47405, USA. Electronic address: [email protected].
• ¹³ Department of Cardiology, Thoracic and Vascular Sciences, School of Medicine, University of Padua, Padua, Italy. Electronic address: [email protected].
• ¹⁴ Experimental and Clinical Toxicology, University of Hamburg Medical School. Hamburg, Germany. Electronic address: [email protected].
• ¹⁵ University of Minnesota Medical School, Duluth, MN, USA. Electronic address: [email protected].
• ¹⁶ Showa Pharmaceutical University, Machida, Tokyo, Japan. Electronic address: [email protected].